What a brutal six months it’s been for Plug Power. The stock has dropped 47.4% and now trades at $1.29, rattling many shareholders. This was partly driven by its softer quarterly results and may ...

This USB-C charger block that supports 3 devices at once is currently 46% off on Amazon and the lowest it's ever been. ... Save 46% on this 3-port fast-charging USB-C wall plug. Buy now at Amazon.

BAAR, Switzerland, May 31, 2025--Novocure (NASDAQ: NVCR) announced that results from the Phase 3 PANOVA-3 trial of Tumor Treating Fields (TTFields) therapy for pancreatic cancer will be presented ...

G-DRAGON Promises to ‘Give My All’ On Stage as K-Pop Star Announces Phase 3 Tour Dates. The musician will play in the U.S. and Europe for his latest run of shows.

Before you buy stock in Plug Power, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Plug Power ...

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt.

WATERTOWN, Mass. - Lyra Therapeutics, Inc. (NASDAQ:LYRA), a clinical-stage biotechnology company, today announced successful outcomes from its ENLIGHTEN 2 Phase 3 clinical trial for LYR-210, a ...

Candidates can complete the registrations for phase 3 through the official website- dost.cgg.gov.in. As per the schedule, the deadline to apply for the TSCHE DOST 2025 admission through web options is ...

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh phase 3 readout. The trial of 1,690 hospitalized patients with ...

Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday.. A total of 106 patients with ...

Don’t discount the Chrysler Pacifica Hybrid because it’s been around since 2017. This is one of the fanciest minivans we’ve driven—here's what we think.

On the basis of phase 2 studies, trastuzumab deruxtecan was approved for patients with human epidermal growth factor receptor 2 (HER2)–positive metastatic gastric cancer or gastroesophageal ...